See analyst estimates and all valuation multiples for Nutraceuticals & Cosmeceuticals
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $22.9B | 1.4x | 6.2x | |
| $21.1B | 18.4x | 57.0x | |
| $16.7B | 10.7x | 31.7x | |
| $9.4B | 3.0x | 7.3x | |
| $8.1B | 10.7x | 39.7x | |
| $6.3B | 4.1x | 20.9x | |
| $4.2B | 13.1x | 31.7x | |
| $4.1B | 2.0x | 13.0x | |
| $3.5B | n/a | n/a | |
| $3.2B | 2.3x | 8.5x | |
| $3.0B | 1.4x | 8.1x | |
| $2.5B | 8.3x | 16.3x | |
| $1.6B | 6.6x | 25.2x | |
| $1.6B | n/a | n/a | |
| $1.3B | 2.2x | 11.3x | |
| $1.1B | 7.7x | 27.3x | |
| $1.1B | 0.9x | 3.8x | |
| $1.0B | n/a | n/a | |
| $998M | n/a | n/a | |
| $992M | 6.4x | 19.5x | |
| $835M | 3.4x | 8.8x | |
| $708M | n/a | n/a | |
| $633M | 12.2x | 34.2x | |
| $627M | 1.4x | 6.6x | |
| $527M | 3.6x | 13.6x | |
| $504M | n/a | n/a | |
| $214M | 3.0x | n/a | |
| $133M | 2.0x | 9.3x | |
| $88.9M | n/a | n/a | |
| $32.5M | n/a | n/a | |
| $25.1M | n/a | n/a | |
| $21.4M | 0.9x | -29.3x | |
| $16.3M | 13.8x | -1.5x | |
| $13.0M | n/a | n/a | |
| $8.1M | n/a | n/a | |
| $4.3M | n/a | n/a | |
| $2.7M | n/a | n/a | |
| -$3.2M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Nutraceuticals & Cosmeceuticals